Home  |  Contact

Cellosaurus RPMI-7932 (CVCL_2713)

[Text version]

Cell line name RPMI-7932
Synonyms RPMI 7932; RPMI7932; Roswell Park Memorial Institute 7932
Accession CVCL_2713
Resource Identification Initiative To cite this cell line use: RPMI-7932 (RRID:CVCL_2713)
Comments Omics: CNV analysis.
Omics: SNP array analysis.
Caution: The exact relationship between HMCB (CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
Sequence variations
Disease Melanoma (NCIt: C3224)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_1122 (CHL-1 )CVCL_RW16 (RPMI-7932 COL-1 )CVCL_RW17 (RPMI-7932 VBL-4 )
CVCL_RW18 (RPMI-7932 VCR-4.5/4 )
Originate from same individual CVCL_3317 ! HMCB
CVCL_T313 ! RPMI-7262
CVCL_T314 ! RPMI-7272
CVCL_T315 ! RPMI-7551
CVCL_T316 ! RPMI-7781
CVCL_T317 ! RPMI-7801
CVCL_T318 ! RPMI-7922
CVCL_T319 ! RPMI-7962
CVCL_T320 ! RPMI-7972
CVCL_T321 ! RPMI-8002
CVCL_T322 ! RPMI-8072
Sex of cell Female
Age at sampling 36Y
Category Cancer cell line

Quinn L.A., Woods L.K., Merrick S.B., Arabasz N.M., Moore G.E.
Cytogenetic analysis of twelve human malignant melanoma cell lines.
J. Natl. Cancer Inst. 59:301-307(1977)

Sharma B.
In vitro immunization against human tumor cells with tumor cell fractions.
Cancer Res. 37:4660-4668(1977)

PubMed=327080; DOI=10.1093/jnci/59.1.221
Fogh J., Fogh J.M., Orfeo T.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
J. Natl. Cancer Inst. 59:221-226(1977)

PubMed=833871; DOI=10.1093/jnci/58.2.209
Fogh J., Wright W.C., Loveless J.D.
Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
J. Natl. Cancer Inst. 58:209-214(1977)

Frampton R.J., Suva L.J., Eisman J.A., Findlay D.M., Moore G.E., Moseley J.M., Martin T.J.
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Cancer Res. 42:1116-1119(1982)

Dracopoli N.C., Fogh J.
Polymorphic enzyme analysis of cultured human tumor cell lines.
J. Natl. Cancer Inst. 70:469-476(1983)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

Lemontt J.F., Azzaria M., Gros P.
Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells.
Cancer Res. 48:6348-6353(1988)

Castellano M., Pollock P.M., Walters M.K., Sparrow L.E., Down L.M., Gabrielli B.G., Parsons P.G., Hayward N.K.
CDKN2A/p16 is inactivated in most melanoma cell lines.
Cancer Res. 57:4868-4875(1997)

PubMed=15048078; DOI=10.1038/sj.onc.1207563
Pavey S., Johansson P., Packer L., Taylor J., Stark M.S., Pollock P.M., Walker G.J., Boyle G.M., Harper U., Cozzi S.-J., Hansen K., Yudt L., Schmidt C., Hersey P., Ellem K.A.O., O'Rourke M.G.E., Parsons P.G., Meltzer P.S., Ringner M., Hayward N.K.
Microarray expression profiling in melanoma reveals a BRAF mutation signature.
Oncogene 23:4060-4067(2004)

PubMed=17363583; DOI=10.1158/0008-5472.CAN-06-4152
Stark M.S., Hayward N.K.
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Cancer Res. 67:2632-2642(2007)

PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676
Dutton-Regester K., Irwin D., Hunt P., Aoude L.G., Tembe V., Pupo G.M., Lanagan C., Carter C.D., O'Connor L., O'Rourke M., Scolyer R.A., Mann G.J., Schmidt C.W., Herington A., Hayward N.K.
A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Mol. Cancer Ther. 11:888-897(2012)

Cell line collections ECACC; 94072246
ICLC; HTL96012
Cell line databases/resources CLO; CLO_0008872
CLDB; cl4180
CLDB; cl4181
Cell_Model_Passport; SIDM00916
Anatomy/cell type resources BTO; BTO:0004062
Encyclopedic resources Wikidata; Q54951231
Gene expression databases GEO; GSM226865
Polymorphism and mutation databases Cosmic; 889039
Cosmic; 928744
Progenetix; CVCL_2713
Entry history
Entry creation04-Apr-2012
Last entry update16-Dec-2021
Version number20